Document details

SAFETY AND EFFICACY OF DOLUTEGRAVIR BASED TRIPLE THERAPY IN HIV-2 INFECTION


Description

Database solution for an HIV-2 cohort study Publication "Real-world experience of TAF/FTC/BIC in people with HIV-2" presented at European AIDS Clinical Society Conference, Oct 2023, Warsaw HIV-2 salvage therapy with Lenacapavir (injectable, capsid inhibitor, EMA approved 2022)

Document Type Conference object
Language English
Contributor(s) Unidade Local de Saúde Amadora / Sintra
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents

No related documents